Excelsior Medical Co (4104.TW) Stock Price

Excelsior Medical Co Price

🇹🇼TWSE·CLOSED
75.50TWD
Market closed
Today +/-
-0.30 TWD
Today %
-0.40 %

Excelsior Medical Co (4104.TW) — ISIN TW0004104005. The Excelsior Medical Co stock price was 75.5 TWD in 2026. Excelsior Medical Co operates in the Health sector.

Excelsior Medical Co stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Excelsior Medical Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Excelsior Medical Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Excelsior Medical Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Excelsior Medical Co Stock Price History
DateExcelsior Medical Co Price
3/19/202675.50 TWD
3/18/202675.80 TWD
3/17/202675.80 TWD
3/16/202675.80 TWD
3/13/202675.70 TWD
3/12/202676.30 TWD
3/11/202676.50 TWD
3/10/202676.60 TWD
3/9/202676.50 TWD
3/6/202678.00 TWD
3/5/202677.80 TWD
2/26/202678.10 TWD
2/25/202678.50 TWD
2/24/202678.90 TWD
2/23/202678.50 TWD
2/11/202677.70 TWD
2/10/202677.60 TWD
2/9/202676.10 TWD
2/6/202676.40 TWD
2/5/202676.20 TWD
2/4/202676.20 TWD
2/3/202676.40 TWD
2/2/202678.00 TWD
1/30/202678.70 TWD
1/29/202678.80 TWD
1/28/202679.20 TWD
1/27/202679.50 TWD
1/26/202679.70 TWD
1/23/202679.00 TWD
1/22/202678.90 TWD
1/21/202678.90 TWD
1/20/202679.40 TWD
1/19/202678.80 TWD
1/16/202679.40 TWD
1/15/202679.70 TWD
1/14/202679.90 TWD
1/13/202679.00 TWD
1/12/202679.20 TWD
1/9/202679.20 TWD
1/8/202679.10 TWD
1/7/202679.10 TWD
1/6/202679.10 TWD
1/5/202679.90 TWD
1/2/202680.80 TWD
12/31/202581.60 TWD
12/30/202582.00 TWD
12/29/202582.00 TWD
12/26/202582.10 TWD
12/24/202581.80 TWD
12/23/202581.60 TWD
12/22/202581.60 TWD
12/19/202581.70 TWD
12/18/202581.40 TWD
12/17/202581.10 TWD
12/16/202581.50 TWD
12/15/202581.70 TWD
12/12/202581.50 TWD
12/11/202581.30 TWD
12/10/202581.20 TWD
12/9/202580.50 TWD
12/8/202581.40 TWD
12/5/202581.60 TWD
12/4/202581.60 TWD
12/3/202581.70 TWD
12/2/202581.60 TWD
12/1/202581.50 TWD
11/28/202582.10 TWD
11/27/202582.10 TWD
11/26/202582.30 TWD
11/25/202582.00 TWD
11/24/202582.40 TWD
11/21/202581.90 TWD
11/20/202581.80 TWD
11/19/202581.20 TWD
11/18/202581.70 TWD
11/17/202583.10 TWD
11/14/202583.70 TWD
11/13/202583.70 TWD
11/12/202583.80 TWD
11/11/202583.60 TWD
11/10/202583.90 TWD
11/7/202585.10 TWD
11/6/202585.40 TWD
11/5/202585.20 TWD
11/4/202585.30 TWD
11/3/202585.20 TWD
10/31/202584.90 TWD
10/30/202584.90 TWD
10/29/202584.90 TWD
10/28/202585.00 TWD
10/27/202585.10 TWD
10/23/202585.00 TWD
10/22/202584.80 TWD
10/21/202585.00 TWD
10/20/202585.20 TWD
10/17/202585.00 TWD
10/16/202584.90 TWD
10/15/202584.90 TWD
10/14/202585.00 TWD
10/13/202585.10 TWD
10/9/202585.10 TWD
10/8/202585.40 TWD
10/7/202585.20 TWD
10/3/202585.60 TWD
10/2/202585.90 TWD
10/1/202586.00 TWD
9/30/202585.80 TWD
9/26/202585.30 TWD
9/25/202585.00 TWD
9/24/202584.90 TWD
9/23/202584.60 TWD
9/22/202584.90 TWD
9/19/202584.70 TWD
9/18/202584.90 TWD
9/17/202585.10 TWD
9/16/202585.30 TWD
9/15/202585.40 TWD
9/12/202586.00 TWD
9/11/202586.10 TWD
9/10/202585.70 TWD
9/9/202584.80 TWD
9/8/202588.40 TWD
9/5/202588.10 TWD
9/4/202588.40 TWD
9/3/202588.10 TWD
9/2/202587.30 TWD
9/1/202587.10 TWD
8/29/202587.20 TWD
8/28/202587.20 TWD
8/27/202587.00 TWD
8/26/202586.60 TWD
8/25/202586.70 TWD
8/22/202586.20 TWD
8/21/202586.30 TWD
8/20/202586.20 TWD
8/19/202586.80 TWD
8/18/202586.20 TWD
8/15/202586.30 TWD
8/14/202586.30 TWD
8/13/202586.30 TWD
8/12/202585.80 TWD
8/11/202586.80 TWD
8/8/202586.00 TWD
8/7/202585.70 TWD
8/6/202585.30 TWD
8/5/202585.30 TWD
8/4/202584.90 TWD
8/1/202584.20 TWD
7/31/202583.90 TWD
7/30/202584.10 TWD
7/29/202584.00 TWD
7/28/202584.10 TWD
7/25/202584.30 TWD
7/24/202584.30 TWD
7/23/202584.20 TWD
7/22/202584.00 TWD
7/21/202584.60 TWD
7/18/202584.60 TWD
7/17/202584.50 TWD
7/16/202583.60 TWD
7/15/202583.70 TWD
7/14/202583.80 TWD
7/11/202584.00 TWD
7/10/202583.70 TWD
7/9/202583.60 TWD
7/8/202583.90 TWD
7/7/202584.10 TWD
7/4/202584.00 TWD
7/3/202584.10 TWD
7/2/202584.30 TWD
7/1/202584.70 TWD
6/30/202584.60 TWD
6/27/202584.90 TWD
6/26/202584.70 TWD
6/25/202584.30 TWD
6/24/202584.10 TWD
6/23/202583.80 TWD
6/20/202584.30 TWD
6/19/202584.50 TWD
6/18/202584.80 TWD
6/17/202584.60 TWD
6/16/202584.90 TWD
6/13/202584.70 TWD
6/12/202585.20 TWD
6/11/202585.60 TWD
6/10/202585.60 TWD
6/9/202585.60 TWD
6/6/202585.70 TWD
6/5/202585.70 TWD
6/4/202585.80 TWD
6/3/202585.30 TWD
6/2/202585.40 TWD
5/29/202585.60 TWD
5/28/202585.80 TWD
5/27/202586.00 TWD
5/26/202586.50 TWD
5/23/202586.30 TWD
5/22/202586.60 TWD
5/21/202586.40 TWD
5/20/202586.40 TWD
5/19/202585.90 TWD
5/16/202586.10 TWD
5/15/202586.50 TWD
5/14/202586.70 TWD
5/13/202586.20 TWD
5/12/202586.70 TWD
5/9/202588.70 TWD
5/8/202589.00 TWD
5/7/202588.20 TWD
5/6/202587.60 TWD
5/5/202586.80 TWD
5/2/202587.00 TWD
4/30/202587.00 TWD
4/29/202586.40 TWD
4/28/202585.60 TWD
4/25/202584.60 TWD
4/24/202584.40 TWD
4/23/202588.20 TWD
4/22/202587.50 TWD
4/21/202587.60 TWD
4/18/202588.60 TWD
4/17/202588.50 TWD
4/16/202588.00 TWD
4/15/202588.20 TWD
4/14/202586.80 TWD
4/11/202587.30 TWD
4/10/202587.20 TWD
4/9/202583.60 TWD
4/8/202584.90 TWD
4/7/202579.90 TWD
4/2/202588.30 TWD
4/1/202588.10 TWD
3/31/202587.70 TWD
3/28/202588.80 TWD
3/27/202589.40 TWD
3/26/202589.80 TWD
3/25/202589.90 TWD
3/24/202590.10 TWD
3/21/202590.40 TWD
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
2.96 B TWD
346 M TWD
242 M TWD
Jan 1, 2006
3.24 B TWD
467 M TWD
338 M TWD
Jan 1, 2007
3.18 B TWD
316 M TWD
1.21 B TWD
Jan 1, 2008
3.26 B TWD
248 M TWD
234 M TWD
Jan 1, 2009
14.3 B TWD
343 M TWD
312 M TWD
Jan 1, 2010
15.36 B TWD
475 M TWD
356 M TWD
Jan 1, 2011
5.99 B TWD
492 M TWD
334 M TWD
Jan 1, 2012
6 B TWD
386 M TWD
276 M TWD
Jan 1, 2013
5.74 B TWD
308 M TWD
300 M TWD
Jan 1, 2014
5.81 B TWD
343.5 M TWD
285.68 M TWD
Jan 1, 2015
6.2 B TWD
348.17 M TWD
378.44 M TWD
Jan 1, 2016
6.21 B TWD
379.5 M TWD
389.56 M TWD
Jan 1, 2017
6.1 B TWD
452.56 M TWD
399.05 M TWD
Jan 1, 2018
6.35 B TWD
438.12 M TWD
451.56 M TWD
Jan 1, 2019
6.46 B TWD
464.04 M TWD
514.76 M TWD
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 20, 2026, 8:14 AM
 
REVENUE (B TWD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B TWD)
NET INCOME (B TWD)
NET INCOME GROWTH (%)
DIV. (TWD)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
20182019202020212022202320242025e
6.356.466.686.577.198.238.549.09
4.101.773.38-1.539.3314.573.706.44
18.9019.1719.5720.9021.0720.2720.8619.60
1.21.241.311.371.511.671.781.78
0.450.510.570.610.670.750.770.93
13.0313.9711.096.309.8811.843.3520.75
2.793.003.303.503.503.653.803.80
11.607.5310.006.06–4.294.11–
162.61162.62175.68176.33176.23176.07176.05176.05
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Excelsior Medical Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Excelsior Medical Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Excelsior Medical Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Excelsior Medical Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Excelsior Medical Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Stock Quarterly Figures

 
REVENUE (B TWD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M TWD)
NET INCOME (M TWD)
NET INCOME GROWTH (%)
DIV. (TWD)
DIV. GROWTH (%)
SHARES (M)
2024 Q12024 Q22024 Q32024 Q42025 Q12025 Q22025 Q32025 Q4e
2.042.162.062.282.152.172.192.35
-6.505.73-4.6310.59-5.620.841.117.03
20.0319.5521.3222.3521.1721.5520.8619.49
409422439509455467457457
185220174192195229186259
-1.6018.92-20.9110.341.5617.44-18.7839.25
3.45---3.62---
––––––––
175.93175.66175.7176.05175.93175.35175.8175.8
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Excelsior Medical Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Excelsior Medical Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Excelsior Medical Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Excelsior Medical Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Excelsior Medical Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co stock margins

The Excelsior Medical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Excelsior Medical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Excelsior Medical Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
31.32 %
11.69 %
8.18 %
Jan 1, 2006
32.58 %
14.4 %
10.42 %
Jan 1, 2007
27.3 %
9.95 %
38.1 %
Jan 1, 2008
25.12 %
7.61 %
7.18 %
Jan 1, 2009
8.87 %
2.4 %
2.18 %
Jan 1, 2010
9.94 %
3.09 %
2.32 %
Jan 1, 2011
23.77 %
8.21 %
5.57 %
Jan 1, 2012
22.65 %
6.43 %
4.6 %
Jan 1, 2013
20.12 %
5.36 %
5.23 %
Jan 1, 2014
20.34 %
5.92 %
4.92 %
Jan 1, 2015
19.85 %
5.61 %
6.1 %
Jan 1, 2016
19.3 %
6.12 %
6.28 %
Jan 1, 2017
19.8 %
7.42 %
6.55 %
Jan 1, 2018
18.9 %
6.9 %
7.12 %
Jan 1, 2019
19.18 %
7.19 %
7.97 %
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Stock Revenue, EBIT, Earnings per Share

The Excelsior Medical Co earnings per share therefore indicates how much revenue Excelsior Medical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
23.68 TWD
2.77 TWD
1.94 TWD
Jan 1, 2006
23.05 TWD
3.32 TWD
2.4 TWD
Jan 1, 2007
23.44 TWD
2.33 TWD
8.93 TWD
Jan 1, 2008
28.9 TWD
2.2 TWD
2.08 TWD
Jan 1, 2009
112.75 TWD
2.7 TWD
2.46 TWD
Jan 1, 2010
114.21 TWD
3.53 TWD
2.65 TWD
Jan 1, 2011
40.06 TWD
3.29 TWD
2.23 TWD
Jan 1, 2012
40.28 TWD
2.59 TWD
1.85 TWD
Jan 1, 2013
38.44 TWD
2.06 TWD
2.01 TWD
Jan 1, 2014
40.46 TWD
2.39 TWD
1.99 TWD
Jan 1, 2015
41.4 TWD
2.32 TWD
2.53 TWD
Jan 1, 2016
38.24 TWD
2.34 TWD
2.4 TWD
Jan 1, 2017
37.51 TWD
2.79 TWD
2.46 TWD
Jan 1, 2018
39.02 TWD
2.69 TWD
2.78 TWD
Jan 1, 2019
39.71 TWD
2.85 TWD
3.17 TWD
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co business model & stock analysis

Excelsior Medical Co Ltd was founded in Hong Kong in 1990 and has since become a leading provider of medical products and solutions for the healthcare sector worldwide. The company aims to offer innovative, reliable, and high-quality products that contribute to increasing efficiency and effectiveness in healthcare. Since its establishment, Excelsior Medical Co Ltd has specialized in various business areas, including the production of surgical instruments and medical devices. Additionally, the company also provides services in the field of medical technology, including consulting, installation, and maintenance of medical devices. The company prides itself on developing and manufacturing innovative products that are in line with the latest innovations and technologies. Excelsior Medical Co Ltd works closely with leading medical research institutes and experts to ensure that their products meet the highest standards. Excelsior Medical Co Ltd's product portfolio includes a variety of products and solutions for the healthcare sector that are used by hospitals and medical facilities worldwide. These products include surgical instruments, anesthesia devices, patient monitoring devices, infusion systems, ventilators, and more. Excelsior Medical Co Ltd is also involved in the manufacturing of consumables for medical facilities. These products include items such as disposable syringes, blood collection tubes, infusion sets, catheters, and other medical devices that have high quality and durability. As a global company, Excelsior Medical Co Ltd has branches and subsidiaries in countries around the world, including China, USA, Europe, and Southeast Asia. This allows the company to provide support and service to its customers worldwide. Overall, the company has gained a reputation as a trusted and reliable partner in the medical industry. Its products and solutions are valued by medical professionals in hospitals, clinics, and care facilities worldwide. Excelsior Medical Co Ltd continues to prioritize innovation and technology in order to offer its customers the best possible products and solutions for the healthcare sector. The company aims to apply its experience and expertise in collaboration with medical experts and research institutions to develop new products and services. This allows them to continue meeting the growing demands of the healthcare industry.

Excelsior Medical Co SWOT Analysis

Strengths

Excelsior Medical Co Ltd possesses several key strengths that contribute to its success and competitiveness in the market:

  • Strong brand reputation and recognition within the medical industry.
  • Broad range of high-quality medical products, catering to various healthcare needs.
  • Innovative and advanced technological capabilities, enabling the development of cutting-edge medical solutions.
  • Established distribution network with effective supply chain management, ensuring timely delivery of products.
  • Skilled and experienced workforce, driving continuous improvement and product innovation.

Weaknesses

Despite its strengths, Excelsior Medical Co Ltd also faces certain weaknesses that pose challenges to its business:

  • Limited global presence, primarily focused in specific geographic regions, hindering market expansion opportunities.
  • Reliance on third-party suppliers for key components, making the supply chain vulnerable to potential disruptions.
  • Bureaucratic decision-making processes, leading to delays in adapting to changing market demands.
  • Lack of effective marketing strategies to promote brand awareness and reach target customers.
  • Higher production costs compared to some competitors, potentially affecting pricing competitiveness.

Opportunities

Excelsior Medical Co Ltd can capitalize on the following opportunities to further enhance its position in the market:

  • Growing demand for advanced medical technologies and solutions, driven by an aging population and increasing healthcare expenditure.
  • Expansion into emerging markets, which offer untapped potential and significant growth opportunities.
  • Collaboration with research institutions and healthcare providers to develop new products and improve existing ones.
  • Integration of digital health technologies to enhance product offerings and provide value-added services.
  • Strategic partnerships with other industry players to leverage complementary strengths and expand market reach.

Threats

Excelsior Medical Co Ltd faces the following threats that may impact its business and market position:

  • Intense competition from established and emerging players, leading to potential price wars and margin erosion.
  • Changing regulatory environment, including stricter quality standards and compliance requirements.
  • Technological advancements by competitors, potentially rendering Excelsior Medical's products obsolete or less competitive.
  • Global economic uncertainties, such as currency fluctuations and trade barriers, affecting export-oriented operations.
  • Reputation risk due to any product recalls, lawsuits, or adverse incidents impacting customer trust and brand image.
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co historical P/E ratio, EBIT multiple, and P/S ratio

Access this data via the Eulerpool API
Get Free API Key
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co shares outstanding

The number of shares was Excelsior Medical Co in 2025 — This indicates how many shares 176.049 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
124.99 M base_Shares
Jan 1, 2006
140.75 M base_Shares
Jan 1, 2007
135.5 M base_Shares
Jan 1, 2008
112.71 M base_Shares
Jan 1, 2009
126.84 M base_Shares
Jan 1, 2010
134.45 M base_Shares
Jan 1, 2011
149.64 M base_Shares
Jan 1, 2012
148.92 M base_Shares
Jan 1, 2013
149.34 M base_Shares
Jan 1, 2014
143.53 M base_Shares
Jan 1, 2015
149.83 M base_Shares
Jan 1, 2016
162.3 M base_Shares
Jan 1, 2017
162.5 M base_Shares
Jan 1, 2018
162.61 M base_Shares
Jan 1, 2019
162.62 M base_Shares
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co stock splits

In Excelsior Medical Co's history, there have been no stock splits.
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Dividend History

25 years of dividend payments

YearAnnual DividendYoY ChangePayments
20253.8TWD 0.0%1×
Apr 24, 20253.8TWD 0.0%1/1
20243.8TWD↑ 4.1%1×
20233.65TWD↑ 4.3%1×
20223.5TWD 0.0%1×
20213.5TWD↑ 6.1%1×
20203.3TWD↑ 10.0%1×
20193TWD↑ 7.4%1×
20182.79TWD↑ 11.9%1×
20172.5TWD↑ 4.3%1×
20162.39TWD↓ 4.3%1×
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co dividend history and estimates

In 2025, Excelsior Medical Co paid a dividend amounting to 3.8 TWD. Dividend means that Excelsior Medical Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2005
1.2 TWD
0 TWD
0 TWD
Jan 1, 2006
1.21 TWD
0 TWD
0 TWD
Jan 1, 2007
4.8 TWD
0 TWD
1.5 TWD
Jan 1, 2008
5 TWD
0 TWD
0 TWD
Jan 1, 2009
1.93 TWD
0 TWD
0 TWD
Jan 1, 2010
1.98 TWD
0 TWD
0 TWD
Jan 1, 2011
2.5 TWD
0 TWD
0 TWD
Jan 1, 2012
0.91 TWD
0 TWD
0 TWD
Jan 1, 2013
2 TWD
0 TWD
0 TWD
Jan 1, 2014
2 TWD
0 TWD
0 TWD
Jan 1, 2015
2.5 TWD
0 TWD
0 TWD
Jan 1, 2016
2.39 TWD
0 TWD
0 TWD
Jan 1, 2017
2.5 TWD
0 TWD
0 TWD
Jan 1, 2018
2.79 TWD
0 TWD
0 TWD
Jan 1, 2019
3 TWD
0 TWD
0 TWD
Access this data via the Eulerpool API
Get Free API Key
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co dividend payout ratio

In 2025, Excelsior Medical Co had a payout ratio of 79.13%. The payout ratio indicates the percentage of the company's profits that Excelsior Medical Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
54.35 %
Jan 1, 2006
47.22 %
Jan 1, 2007
46.13 %
Jan 1, 2008
180.66 %
Jan 1, 2009
59.01 %
Jan 1, 2010
56.03 %
Jan 1, 2011
83.85 %
Jan 1, 2012
40.43 %
Jan 1, 2013
82.27 %
Jan 1, 2014
82.68 %
Jan 1, 2015
81.62 %
Jan 1, 2016
82.04 %
Jan 1, 2017
83.86 %
Jan 1, 2018
82.96 %
Jan 1, 2019
78.1 %
Access this data via the Eulerpool API
Get Free API Key
Price targets and forecasts for Excelsior Medical Co are not yet available.
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co shareholder structure

% Name
9.69369%
Chia Yih Investment Company Ltd.
Chia Yih Investment Company Ltd.
9.17715%
Chia Ho Investment Company Ltd.
Chia Ho Investment Company Ltd.
8.52100%
Bestchain Healthtaiwan Co., Ltd.
Bestchain Healthtaiwan Co., Ltd.
2.58109%
Chiu Yu Investment Company Ltd.
Chiu Yu Investment Company Ltd.
2.34698%
Xuan Hui Investment Co., Ltd.
Xuan Hui Investment Co., Ltd.
1.34776%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.92159%
Lin (Junyao)
Lin (Junyao)
0.53459%
Bank Sinopac Company Ltd.
Bank Sinopac Company Ltd.
0.44328%
ING Pension Fund
ING Pension Fund
0.39391%
Hsieh (Yen Sheng)
Hsieh (Yen Sheng)
Access this data via the Eulerpool API
Get Free API Key

Excelsior Medical Co Executives and Management Board

HF

Huidong Fu

Chairman of the Board · since 2001

QC

Qixiu Chen

Vice Chairman of the Board

SG

Sheng Gao

Vice Chairman of the Board · since 2005

CZ

Chenxiao Zhou

Chief Financial Officer, Deputy General Manager, Corporate Governance Officer

MZ

Mingzheng Zhang

General Manager

Access this data via the Eulerpool API
Get Free API Key

Frequently asked questions about Excelsior Medical Co

The business model of Excelsior Medical Co Ltd is focused on the development, manufacturing, and distribution of medical devices and products. With a strong emphasis on innovation and quality, Excelsior Medical Co Ltd aims to provide effective and reliable solutions for healthcare professionals and patients worldwide. By continuously investing in research and development, the company strives to introduce new and advanced technologies that meet the evolving needs of the medical industry. Excelsior Medical Co Ltd is committed to delivering safe and efficient medical products to enhance patient outcomes and improve overall healthcare practices.

Access this data via the Eulerpool API
Get Free API Key

All fundamentals and in-depth analysis of Excelsior Medical Co

Our stock analysis for Excelsior Medical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Excelsior Medical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Excelsior Medical Co Stock
Excelsior Medical Co Revenue→
Excelsior Medical Co Stock
Excelsior Medical Co Net Income→
Excelsior Medical Co Stock
Excelsior Medical Co P/E→
Excelsior Medical Co Stock
Excelsior Medical Co P/S→
Excelsior Medical Co Stock
Excelsior Medical Co EBIT→
Excelsior Medical Co Stock
Excelsior Medical Co Dividend→
Excelsior Medical Co Stock
Excelsior Medical Co Directors Dealings→
Excelsior Medical Co Stock
Excelsior Medical Co Stocks→
Excelsior Medical Co Stock
Excelsior Medical Co Market capitalization→
Excelsior Medical Co Stock
Excelsior Medical Co Debt→
Excelsior Medical Co Stock
Excelsior Medical Co Liabilities→
Excelsior Medical Co Stock
Excelsior Medical Co Equity→
Excelsior Medical Co Stock
Excelsior Medical Co AAQS→
Excelsior Medical Co Stock
Excelsior Medical Co Employees→
Excelsior Medical Co Stock
Excelsior Medical Co ROE→
Excelsior Medical Co Stock
Excelsior Medical Co ROA→
Excelsior Medical Co Stock
Excelsior Medical Co ROCE→